The usamricd medical toxicology research division has a requirement for surgical support services to perform surgical implantation of telemetry transmitters in ten gottingen minipigs.
Ended Awarded Last action
- Contract number
- HT942524F0003
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $116,325
Award facts
- Contract value 100% obligated
- $116,324.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- ABER PROV GRD, MD 21010, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) Medical Toxicology Research Division awarded a $116,324.60 firm fixed-price call order to Harvard Bioscience Inc., operating as Data Sciences International, on December 22, 2023, with completion targeted for January 25, 2024. This contract call, issued without set-aside designation, was executed under a broader $4.8 million Blanket Purchase Agreement with the Defense Health Agency established in May 2022. The requirement is for surgical support services to perform surgical implantation of telemetry transmitters in ten Göttingen minipigs at Aberdeen Proving Ground, Maryland, where the company will leverage its specialized expertise in wireless implantable physiological monitoring technologies.
Harvard Bioscience, a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, has established itself as a critical supplier of biomedical research equipment and services to the Defense Health Agency and other federal agencies. The company's Data Sciences International division specializes in developing and manufacturing advanced physiological monitoring systems, including wireless implantable telemetry devices, data acquisition software, and surgical implantation services across various animal models. This contract represents one of numerous task orders issued under the Defense Health Agency BPA, which has generated over $1.5 million in cumulative procurement value and encompasses surgical implantation procedures, telemetry equipment acquisition, pre-implanted animals, and related research support services utilized by the military health system and research community.
Quick answers
Who was awarded contract HT942524F0003?
HT942524F0003 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on December 22, 2023.
How much is contract HT942524F0003 worth?
The government has obligated $116,325 on HT942524F0003.
Is contract HT942524F0003 an order under another contract?
Yes. HT942524F0003 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT942524F0003 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award